NYSE:PRGO - Perrigo Stock Price, Price Target & More

Get Started

$75.16 -0.81 (-1.07 %)

(As of 05/23/2018 04:00 PM ET)

Previous Close$75.97

Today's Range$74.97 - $76.25

52-Week Range$63.68 - $95.93

Volume990,300 shs

Average Volume1.10 million shs

Market Capitalization$10.48 billion

P/E Ratio15.25

Dividend Yield1.00%

Beta0.77

About Perrigo (NYSE:PRGO)

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments. It offers OTC products in cough, cold, allergy, sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic, lifestyle, personal care and derma-therapeutics, natural health and vitamins, and anti-parasite categories. The company also develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services. The company offers its products through retail drug, supermarket, and mass merchandise chains; hospitals; pharmacies; wholesalers; drug and grocery stores; and para pharmacies, as well as through a network of pharmacy sales force in North America, Europe, Australia, Israel, and China. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Receive PRGO News and Ratings via Email

Sign-up to receive the latest news and ratings for PRGO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations

Sub-IndustryPharmaceuticals

SectorMedical

SymbolNYSE:PRGO

CUSIP71429010

Webwww.perrigo.com

Phone353-1709-4000

Debt

Debt-to-Equity Ratio0.53

Current Ratio2.08

Quick Ratio1.48

Price-To-Earnings

Trailing P/E Ratio15.25

Forward P/E Ratio14.32

P/E Growth1.78

Sales & Book Value

Annual Sales$4.95 billion

Price / Sales2.10

Cash Flow$7.9366 per share

Price / Cash9.47

Book Value$44.82 per share

Price / Book1.68

Profitability

EPS (Most Recent Fiscal Year)$4.93

Net Income$119.60 million

Net Margins2.59%

Return on Equity11.93%

Return on Assets6.23%

Miscellaneous

Employees10,400

Outstanding Shares138,460,000

Perrigo (NYSE:PRGO) Frequently Asked Questions

What is Perrigo's stock symbol?

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

How often does Perrigo pay dividends? What is the dividend yield for Perrigo?

Perrigo declared a quarterly dividend on Thursday, May 3rd. Stockholders of record on Friday, June 1st will be paid a dividend of $0.19 per share on Tuesday, June 19th. This represents a $0.76 annualized dividend and a dividend yield of 1.01%. The ex-dividend date is Thursday, May 31st. View Perrigo's Dividend History.

How were Perrigo's earnings last quarter?

Perrigo (NYSE:PRGO) issued its quarterly earnings data on Tuesday, May, 8th. The company reported $1.26 earnings per share for the quarter, beating analysts' consensus estimates of $1.14 by $0.12. The firm had revenue of $1.22 billion for the quarter, compared to analysts' expectations of $1.21 billion. Perrigo had a net margin of 2.59% and a return on equity of 11.93%. The company's revenue was up 1.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.05 EPS. View Perrigo's Earnings History.

When is Perrigo's next earnings date?

Perrigo is scheduled to release their next quarterly earnings announcement on Thursday, August, 9th 2018. View Earnings Estimates for Perrigo.

What guidance has Perrigo issued on next quarter's earnings?

Perrigo issued an update on its FY18 earnings guidance on Tuesday, May, 8th. The company provided EPS guidance of $5.05-5.45 for the period, compared to the Thomson Reuters consensus estimate of $5.26.

What price target have analysts set for PRGO?

17 Wall Street analysts have issued twelve-month price targets for Perrigo's stock. Their predictions range from $79.00 to $117.00. On average, they anticipate Perrigo's stock price to reach $93.0625 in the next twelve months. View Analyst Ratings for Perrigo.

Who are some of Perrigo's key competitors?

Some companies that are related to Perrigo include Zoetis (ZTS), Vertex Pharmaceuticals (VRTX), Takeda Pharmaceutical (TKPYY), Regeneron (REGN), Astellas Pharma (ALPMY), Shiseido (SSDOY), Alexion Pharmaceuticals (ALXN), Teva Pharmaceutical Industries (TEVA), Mylan (MYL), BioMarin Pharmaceutical (BMRN), Grifols (GRFS), UCB (UCBJF), Nektar Therapeutics (NKTR), Ono Pharmaceutical (OPHLF) and Merck Group (MKGAF).

Who are Perrigo's key executives?

Perrigo's management team includes the folowing people:

Mr. Todd W. Kingma, Exec. VP, Gen. Counsel & Sec. (Age 58)
Mr. Sharon Kochan, Exec. VP & Pres of Consumer Healthcare International (Age 50)
Mr. Jeffrey R. Needham, Exec. VP & Pres of Consumer Healthcare Americas (Age 62)
Mr. Uwe F. Röehrhoff, Pres, CEO & Director (Age 56)
Mr. Ronald L. Winowiecki, Chief Financial Officer (Age 52)

Has Perrigo been receiving favorable news coverage?

News articles about PRGO stock have trended somewhat positive recently, according to Accern. Accern scores the sentiment of press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Perrigo earned a media sentiment score of 0.20 on Accern's scale. They also gave news coverage about the company an impact score of 45.90 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

Who are Perrigo's major shareholders?

Perrigo's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (6.17%), Franklin Resources Inc. (5.86%), Victory Capital Management Inc. (1.75%), Clal Insurance Enterprises Holdings Ltd (1.39%), Manning & Napier Group LLC (1.23%) and Millennium Management LLC (1.02%). Company insiders that own Perrigo stock include Gary K Kunkle Jr, Geoffrey M Parker, Herman Morris Jr, Jeffrey C Smith, Jeffrey Needham, John Wesolowski, Judy L Brown, Sharon Kochan, Thomas Farrington, Todd W Kingma and Uwe Roehrhoff. View Institutional Ownership Trends for Perrigo.

Which institutional investors are selling Perrigo stock?

PRGO stock was sold by a variety of institutional investors in the last quarter, including Manning & Napier Group LLC, Migdal Insurance & Financial Holdings Ltd., Sector Gamma AS, Swiss National Bank, Millennium Management LLC, UBS Group AG, Quadrature Capital Ltd and Engineers Gate Manager LP. Company insiders that have sold Perrigo company stock in the last year include Jeffrey Needham, John Wesolowski, Sharon Kochan, Thomas Farrington and Todd W Kingma. View Insider Buying and Selling for Perrigo.

Which institutional investors are buying Perrigo stock?

PRGO stock was purchased by a variety of institutional investors in the last quarter, including Ceredex Value Advisors LLC, Clal Insurance Enterprises Holdings Ltd, Victory Capital Management Inc., New York State Common Retirement Fund, Point72 Asset Management L.P., Franklin Resources Inc., Prudential Financial Inc. and Dimensional Fund Advisors LP. Company insiders that have bought Perrigo stock in the last two years include Geoffrey M Parker, Jeffrey C Smith, John Wesolowski and Uwe Roehrhoff. View Insider Buying and Selling for Perrigo.

How do I buy shares of Perrigo?

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Perrigo's stock price today?

One share of PRGO stock can currently be purchased for approximately $75.16.

How big of a company is Perrigo?

Perrigo has a market capitalization of $10.48 billion and generates $4.95 billion in revenue each year. The company earns $119.60 million in net income (profit) each year or $4.93 on an earnings per share basis. Perrigo employs 10,400 workers across the globe.

How can I contact Perrigo?

Perrigo's mailing address is TREASURY BUILDING LOWER GRAND CANAL STREET, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]

MarketBeat Community Rating for Perrigo (PRGO)

Community Ranking:		2.6 out of 5 ( )
Outperform Votes:		561 (Vote Outperform)
Underperform Votes:		519 (Vote Underperform)
Total Votes:		1,080

MarketBeat's community ratings are surveys of what our community members think about Perrigo and other stocks. Vote "Outperform" if you believe PRGO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRGO will underperform the S&P 500 over the long term. You may vote once every thirty days.

Perrigo (NYSE:PRGO) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

17 Wall Street analysts have issued ratings and price targets for Perrigo in the last 12 months. Their average twelve-month price target is $93.0625, suggesting that the stock has a possible upside of 23.82%. The high price target for PRGO is $117.00 and the low price target for PRGO is $79.00. There are currently 8 hold ratings and 9 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	2.53	2.53	2.56	2.53
Ratings Breakdown:	0 Sell Rating(s) 8 Hold Rating(s) 9 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 8 Hold Rating(s) 9 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 8 Hold Rating(s) 10 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 7 Hold Rating(s) 8 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$93.0625	$93.4375	$93.4706	$91.50
Price Target Upside:	23.82% upside	14.12% upside	3.12% upside	6.40% upside

Perrigo (NYSE:PRGO) Consensus Price Target History

Price Target History for Perrigo (NYSE:PRGO)

Perrigo (NYSE:PRGO) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
5/23/2018	Cantor Fitzgerald	Set Price Target	Buy	$107.00	Low
5/14/2018	Canaccord Genuity	Set Price Target	Buy	$105.00	Low
5/14/2018	Wells Fargo & Co	Lower Price Target	Market Perform ➝ Market Perform	$90.00 ➝ $84.00	High
5/11/2018	Oppenheimer	Set Price Target	Buy	$98.00	Low
3/5/2018	JPMorgan Chase & Co.	Reiterated Rating	Neutral ➝ Neutral	$82.00 ➝ $83.00	Low
2/1/2018	Berenberg Bank	Initiated Coverage	Buy	$117.00	Low
1/2/2018	Leerink Swann	Initiated Coverage	Mkt Perform ➝ Market Perform	$90.00	Low
12/8/2017	Argus	Upgrade	Hold ➝ Buy	$93.00	Medium
12/4/2017	Barclays	Boost Price Target	Overweight	$93.00	Medium
11/10/2017	Jefferies Group	Reiterated Rating	Hold	$81.00	N/A
11/10/2017	Morgan Stanley	Boost Price Target	Equal Weight	$79.00 ➝ $92.00	N/A
11/10/2017	Royal Bank of Canada	Upgrade	Underperform ➝ Sector Perform	$64.00 ➝ $86.00	N/A
10/5/2017	UBS	Reiterated Rating	Buy ➝ Buy	$84.00 ➝ $98.00	N/A
9/14/2017	Deutsche Bank	Boost Price Target	Buy	$88.00 ➝ $95.00	Low
9/7/2017	CIBC	Initiated Coverage	Outperform ➝ Outperform	$88.00	Low
8/11/2017	Stifel Nicolaus	Reiterated Rating	Hold		Low
8/11/2017	Goldman Sachs Group	Upgrade	Sell ➝ Neutral	$66.00 ➝ $79.00	Medium
4/22/2017	B. Riley	Reiterated Rating	Neutral	$67.00	Medium
2/28/2017	Guggenheim	Reiterated Rating	Buy	$125.00	N/A
11/11/2016	Bank of America	Upgrade	Underperform ➝ Neutral		N/A
8/11/2016	Northland Securities	Downgrade	Outperform ➝ Market Perform	$123.00 ➝ $94.00	N/A
6/17/2016	BTIG Research	Reiterated Rating	Neutral		N/A
6/15/2016	Raymond James	Reiterated Rating	Hold		N/A

(Data available from 5/23/2016 forward)

Perrigo (NYSE:PRGO) Earnings History and Estimates Chart

Earnings by Quarter for Perrigo (NYSE:PRGO)

Perrigo (NYSE:PRGO) Earnings Estimates

2018 EPS Consensus Estimate: $5.29

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	3	$1.13	$1.24	$1.17
Q2 2018	3	$1.19	$1.40	$1.29
Q3 2018	3	$1.24	$1.38	$1.30
Q4 2018	3	$1.47	$1.61	$1.53

Perrigo (NYSE PRGO) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
8/7/2018		$1.24					N/A
5/8/2018	3/31/2018	$1.14	$1.26	$1.2089 billion	$1.2170 billion	View	Listen
3/1/2018	Q4 17	$1.25	$1.28	$1.2623 billion	$1.2830 billion	View	Listen
11/9/2017	Q3 17	$1.11	$1.39	$1.1669 billion	$1.2150 billion	View	N/A
8/10/2017	6/30/2017	$0.94	$1.22	$1.1771 billion	$1.2380 billion	View	N/A
5/30/2017	Q1 17	$0.99	$1.05	$1.1922 billion	$1.1940 billion	View	N/A
5/22/2017	12/31/2016	$1.76	$1.24	$1.3874 billion	$1.3310 billion	View	N/A
11/10/2016	Q316	$1.58	$1.65	$1.28 billion	$1.40 billion	View	N/A
8/10/2016	Q216	$1.98	$1.93	$1.43 billion	$1.48 billion	View	Listen
5/12/2016	Q116	$1.75	$1.75	$1.35 billion	$1.34 billion	View	Listen
2/18/2016	Q415	$1.93	$1.80	$1.46 billion	$1.42 billion	View	Listen
10/22/2015	Q3	$1.73	$1.76	$1.42 billion	$1.34 billion	View	Listen
8/5/2015	Q2	$1.96	$2.18	$1.52 million	$1.53 million	View	N/A
4/21/2015	Q315	$1.78	$1.85	$1.1012 billion	$1.0490 billion	View	N/A
2/5/2015	Q215	$1.79	$1.82	$1.09 billion	$1.07 billion	View	N/A
11/6/2014	Q115	$1.44	$1.40	$997.90 million	$951.50 million	View	N/A
8/14/2014	Q414	$1.55	$1.74	$1.09 billion	$1.14 billion	View	N/A
5/7/2014	Q314	$1.51	$1.31	$1.07 billion	$1,000.00 million	View	N/A
2/6/2014	Q214	$1.59	$1.87	$996.68 million	$979.00 million	View	N/A
10/31/2013	Q114	$1.40	$1.52	$900.10 million	$933.00 million	View	N/A
8/15/2013	Q4 2013	$1.56	$1.57	$999.08 million	$967.20 million	View	N/A
5/7/2013	Q3 2013	$1.44	$1.42	$935.44 million	$919.83 million	View	N/A
2/1/2013	Q2 2013	$1.31	$1.36	$881.84 million	$882.96 million	View	N/A
11/7/2012	Q113	$1.24	$1.27	$825.83 million	$769.80 million	View	N/A
8/16/2012		$1.27	$1.28			View	N/A
5/8/2012		$1.22	$1.41			View	N/A
2/7/2012		$1.15	$1.20			View	N/A
10/27/2011		$1.06	$1.10			View	N/A
8/16/2011		$0.97	$1.02			View	N/A
5/3/2011		$0.97	$1.07			View	N/A
2/1/2011		$0.95	$1.05			View	N/A
11/2/2010	Q3 2010	$0.77	$0.87			View	N/A
8/12/2010	Q2 2010	$0.68	$0.71			View	N/A
4/29/2010	Q1 2010	$0.63	$0.76			View	N/A
2/2/2010	Q4 2009	$0.66	$0.70			View	N/A
11/2/2009	Q3 2009	$0.49	$0.66			View	N/A
8/18/2009	Q2 2009	$0.46	$0.50			View	N/A
5/7/2009	Q1 2009	$0.45	$0.51			View	N/A
2/3/2009	Q4 2008	$0.50	$0.46			View	N/A
11/6/2008	Q3 2008	$0.42	$0.41			View	N/A
8/18/2008	Q2 2008	$0.40	$0.39			View	N/A
5/6/2008	Q1 2008	$0.42	$0.44			View	N/A
2/5/2008	Q4 2007	$0.34	$0.36			View	N/A

(Earnings results data provided by Zacks Investment Research)

Perrigo (NYSE:PRGO) Dividend Information

Perrigo pays an annual dividend of $0.76 per share, with a dividend yield of 1.01%. PRGO's next quarterly dividend payment will be made on Tuesday, June 19. The company has grown its dividend for the last 15 consecutive years and is increasing its dividend by an average of 15.10% each year. Perrigo pays out 15.42% of its earnings out as a dividend.

Next Dividend:	6/19/2018
Annual Dividend:	$0.76
Dividend Yield:	1.01%
Dividend Growth:	15.10% (3 Year Average)
Payout Ratio(s):	15.42% (Trailing 12 Months of Earnings) 14.48% (Based on This Year's Estimates) 13.33% (Based on Next Year's Estimates) 9.58% (Based on Cash Flow)
Track Record:	15 Years of Consecutive Dividend Growth
Frequency:	Quarterly Dividend

Dividend Payments by Quarter for Perrigo (NYSE:PRGO)

Perrigo (NYSE:PRGO) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/3/2018	quarterly	$0.19	1.02%	5/31/2018	6/1/2018	6/19/2018
2/15/2018	quarterly	$0.19	0.91%	3/1/2018	3/2/2018	3/20/2018
11/2/2017	quarterly	$0.16	0.77%	11/30/2017	12/1/2017	12/19/2017
8/8/2017	Quarterly	$0.16	0.96%	8/23/2017	8/25/2017	9/12/2017
5/3/2017	quarterly	$0.16	0.88%	5/24/2017	5/26/2017	6/13/2017
2/21/2017	quarterly	$0.16	0.76%	3/1/2017	3/3/2017	3/21/2017
11/8/2016	quarterly	$0.1450	0.69%	11/22/2016	11/25/2016	12/13/2016
8/2/2016	quarterly	$0.1450	0.62%	8/24/2016	8/26/2016	9/13/2016
4/26/2016		$0.1450		5/25/2016	5/27/2016	6/14/2016
4/26/2016	quarterly	$0.1450		5/25/2016	5/27/2016	6/14/2016
2/16/2016	quarterly	$0.1450		2/24/2016	2/26/2016	3/15/2016
11/4/2015	quarterly	$0.1250		11/24/2015	11/27/2015	12/15/2015
8/12/2015	quarterly	$0.1250		8/26/2015	8/28/2015	9/15/2015
4/29/2015	quarterly	$0.1250	0.27%	5/27/2015	5/29/2015	6/16/2015
1/27/2015	quarterly	$0.1250		2/25/2015	2/27/2015	3/17/2015
11/3/2014	quarterly	$0.1050	0.26%	11/27/2014	11/28/2014	12/16/2014
8/13/2014	quarterly	$0.1050	0.28%	8/27/2014	8/29/2014	9/16/2014
4/28/2014	quarterly	$0.1050	0.29%	5/28/2014	5/30/2014	6/17/2014
1/29/2014	quarterly	$0.1050	0.27%	2/26/2014	2/28/2014	3/18/2014
11/6/2013	quarterly	$0.09	0.25%	11/26/2013	11/29/2013	12/17/2013
8/14/2013	quarterly	$0.09	0.29%	8/28/2013	8/30/2013	9/17/2013
5/2/2013	quarterly	$0.09	0.3%	5/29/2013	5/31/2013	6/18/2013
1/31/2013	quarterly	$0.09	0.34%	2/27/2013	3/1/2013	3/19/2013

(Data available from 1/1/2013 forward)

Perrigo (NYSE PRGO) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 6.90%
Institutional Ownership Percentage: 80.22%

Insider Trading History for Perrigo (NYSE:PRGO)

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

Perrigo (NYSE PRGO) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/17/2018	Jeffrey C Smith	Director	Buy	50,000	$75.89	$3,794,500.00	528
5/15/2018	Jeffrey C Smith	Director	Buy	250,000	$75.21	$18,802,500.00	528
3/5/2018	Uwe Roehrhoff	CEO	Buy	7,500	$81.85	$613,875.00	4,900
12/28/2017	Todd W Kingma	VP	Sell	1,500	$88.52	$132,780.00	19,565
12/28/2017	Todd W Kingma	VP	Sell	1,500	$88.52	$132,780.00	19,565
12/14/2017	John Wesolowski	EVP	Buy	700	$85.80	$60,060.00
12/7/2017	John Wesolowski	EVP	Sell	450	$83.09	$37,390.50
11/29/2017	John Wesolowski	EVP	Sell	388	$87.20	$33,833.60	248
11/16/2017	Thomas Farrington	EVP	Sell	213	$87.26	$18,586.38	3,347
9/12/2017	Jeffrey Needham	EVP	Sell	3,595	$89.49	$321,716.55	10,118
9/7/2017	Sharon Kochan	EVP	Sell	318	$81.36	$25,872.48	10,231
8/31/2017	Sharon Kochan	EVP	Sell	1,500	$79.03	$118,545.00	10,349
8/30/2017	Thomas Farrington	EVP	Sell	616	$76.90	$47,370.40	2,724
8/18/2017	Thomas Farrington	EVP	Sell	865	$78.40	$67,816.00	2,870
11/25/2016	Judy L Brown	EVP	Sell	2,097	$89.44	$187,555.68	10,007
11/21/2016	Geoffrey M Parker	Director	Buy	2,500	$88.75	$221,875.00
10/24/2016	Judy L Brown	EVP	Sell	2,092	$90.42	$189,158.64	12,104
9/26/2016	Judy L Brown	CFO	Sell	2,096	$96.76	$202,808.96	14,196
9/26/2016	Thomas Farrington	EVP	Sell	1,110	$96.76	$107,403.60	2,970
9/9/2016	Gary K Kunkle Jr	Director	Sell	5,814	$89.95	$522,969.30	31,501
9/8/2016	Herman Morris Jr	Director	Sell	1,073	$90.96	$97,600.08	10,425
8/26/2016	Judy L Brown	EVP	Sell	2,095	$88.28	$184,946.60	16,292
4/13/2016	Judy L Brown	CFO	Sell	2,776	$126.22	$350,386.72	13,924
3/18/2016	Michael J Jandernoa	Director	Sell	761	$128.29	$97,628.69	8,611
3/2/2016	Sharon Kochan	EVP	Sell	1,490	$125.28	$186,667.20	5,883
2/24/2016	Judy L Brown	CFO	Sell	2,776	$123.73	$343,474.48	13,924
1/6/2016	Judy L. Brown	CFO	Sell	27,737	$142.41	$3,950,026.17	12,429
12/28/2015	Joseph C. Papa	Chairman	Sell	10,183	$147.07	$1,497,613.81	118,515
8/25/2015	John T. Hendrickson	EVP	Sell	1,737	$181.37	$315,039.69
8/25/2015	Todd W. Kingma	VP	Sell	1,715	$181.37	$311,049.55	10,320
8/24/2015	John T. Hendrickson	EVP	Sell	4,468	$177.68	$793,874.24	1,737
4/29/2015	Todd W Kingma	VP	Sell	1,700	$190.27	$323,459.00
4/14/2015	John T Hendrickson	EVP	Sell	8,800	$200.27	$1,762,376.00
4/13/2015	Todd W Kingma	VP	Sell	1,300	$198.44	$257,972.00
3/13/2015	Jatin Shah	SVP	Sell	2,000	$165.50	$331,000.00
10/1/2014	Judy L Brown	CFO	Sell	3,515	$150.72	$529,780.80
9/3/2014	Sharon Kochan	EVP	Sell	1,116	$150.00	$167,400.00
9/3/2014	Todd W Kingma	VP	Sell	2,250	$149.65	$336,712.50
9/2/2014	Judy L Brown	CFO	Sell	3,515	$149.32	$524,859.80
9/2/2014	Thomas Farrington	VP	Sell	1,741	$150.36	$261,776.76
8/27/2014	Michael Robert Stewart	VP	Sell	4,519	$148.78	$672,336.82
8/26/2014	Jeffrey Needham	VP	Sell	10,205	$148.54	$1,515,850.70
8/26/2014	Judy L Brown	CFO	Sell	4,827	$148.87	$718,595.49
8/25/2014	John T Hendrickson	EVP	Sell	2,533	$148.44	$375,998.52
5/15/2014	Ran Gottfried	Director	Sell	1,000	$131.25	$131,250.00	12,159
3/24/2014	Joseph Papa	Chairman	Sell	10,000	$157.72	$1,577,200.00	95,500
1/16/2014	Joseph Papa	Chairman	Sell	5,000	$157.59	$787,950.00	96,655
12/12/2013	Gary Cohen	Director	Sell	4,632	$152.52	$706,472.64	11,868
12/12/2013	Joseph Papa	Chairman	Sell	15,000	$150.12	$2,251,800.00	96,655
12/9/2013	Michael Jandernoa	Director	Sell	128,620	$155.30	$19,974,686.00	868
11/25/2013	Louis Yu	VP	Sell	2,292	$155.51	$356,428.92	8,548
11/21/2013	Judy Brown	CFO	Sell	9,988	$154.74	$1,545,543.12	7,445
11/20/2013	John Hendrickson	EVP	Sell	8,400	$152.80	$1,283,520.00
11/4/2013	Ran Gottfried	Director	Sell	2,275	$143.36	$326,144.00	11,609
9/24/2013	Joseph Papa	Chairman	Sell	15,000	$124.60	$1,869,000.00	116,655
9/18/2013	John Hendrickson	EVP	Sell	2,161	$125.00	$270,125.00
9/11/2013	Michael Robert Stewart	VP	Sell	5,063	$123.37	$624,622.31
9/9/2013	Louis Yu	VP	Sell	1,852	$124.11	$229,851.72
9/6/2013	John T Hendrickson	EVP	Sell	1,000	$123.46	$123,460.00
9/4/2013	John T Hendrickson	EVP	Sell	2,000	$123.92	$247,840.00
9/3/2013	Judy Brown	CFO	Sell	2,500	$122.07	$305,175.00	17,433
8/30/2013	Jeffrey Needham	VP	Sell	6,585	$120.47	$793,294.95	5,199
8/29/2013	Sharon Kochan	VP	Sell	3,467	$120.98	$419,437.66	5,541
8/27/2013	Joseph Papa	Chairman	Sell	15,000	$117.64	$1,764,600.00	118,455
8/26/2013	John Hendrickson	EVP	Sell	2,099	$119.15	$250,095.85
8/26/2013	Judy Brown	CFO	Sell	3,424	$119.28	$408,414.72	17,433
8/20/2013	John Hendrickson	EVP	Sell	1,676	$118.56	$198,706.56
8/20/2013	Judy Brown	CFO	Sell	2,804	$118.58	$332,498.32	17,433
8/20/2013	Thomas Farrington	VP	Sell	1,658	$119.86	$198,727.88	1,040
8/16/2013	Todd Kingma	VP	Sell	1,250	$120.00	$150,000.00	17,065
7/19/2013	Todd W Kingma	VP	Sell	1,250	$129.37	$161,712.50
7/11/2013	Joseph C Papa	Chairman	Sell	10,000	$128.54	$1,285,400.00
7/9/2013	John T Hendrickson	EVP	Sell	2,161	$125.00	$270,125.00
6/14/2013	Joseph C Papa	Chairman	Sell	10,000	$118.39	$1,183,900.00
6/14/2013	Todd W Kingma	VP	Sell	1,250	$118.00	$147,500.00
6/4/2013	Judy L Brown	CFO	Sell	2,500	$116.38	$290,950.00
5/14/2013	Sharon Kochan	VP	Sell	2,647	$119.64	$316,687.08	5,492

(Data available from 1/1/2013 forward)

Perrigo (NYSE PRGO) News Headlines

Source:

Date	Headline
	Cantor Fitzgerald Analysts Give Perrigo (PRGO) a $107.00 Price Target www.americanbankingnews.com - May 23 at 12:54 PM
	Starboard Value Buys $30.2 Million More in Perrigo Stock finance.yahoo.com - May 21 at 4:56 PM
	Perrigo (PRGO) Director Jeffrey C. Smith Purchases 50,000 Shares www.americanbankingnews.com - May 17 at 10:26 PM
	Insider Buying: Perrigo (PRGO) Director Buys 250,000 Shares of Stock www.americanbankingnews.com - May 17 at 10:26 PM
	Is There An Opportunity With Perrigo Company plc’s (NYSE:PRGO) 30% Undervaluation? finance.yahoo.com - May 17 at 5:43 PM
	BRIEF-Aspen's Infant Formula Unit Is Said To Draw Reckitt, Perrigo - Bloomberg www.reuters.com - May 16 at 5:13 PM
	Aspen's Infant Formula Unit Is Said to Draw Reckitt, Perrigo finance.yahoo.com - May 16 at 8:52 AM
	Perrigo (PRGO) Given a $107.00 Price Target at Cantor Fitzgerald www.americanbankingnews.com - May 15 at 1:11 PM
	Perrigo (PRGO) PT Set at $105.00 by Canaccord Genuity www.americanbankingnews.com - May 15 at 1:07 PM
	Perrigo Co. (PRGO) PT Lowered to $93 at Deutsche Bank; 'Generic ProAir CRL a Little Disappointing... Lowers EPS ... www.streetinsider.com - May 15 at 8:59 AM
	Perrigo Target of Unusually Large Options Trading (PRGO) www.americanbankingnews.com - May 15 at 6:48 AM
	Perrigo (PRGO) Expected to Announce Quarterly Sales of $1.24 Billion www.americanbankingnews.com - May 15 at 4:40 AM
	US STOCKS ON THE MOVE-NXP, Symantec, Precipio, Perrigo www.nasdaq.com - May 14 at 5:04 PM
	BRIEF-Perrigo Confirms First To File Patent Challenge For Generic Ultravate Lotion www.reuters.com - May 14 at 5:04 PM
	Morning Movers: Qualcomm, NXP Jump as China Restarts Merger Review, Perrigo Drops on Drug Review www.barrons.com - May 14 at 5:04 PM
	Perrigo Confirms First To File Patent Challenge For Generic Version Of Ultravate® Lotion, 0.05% finance.yahoo.com - May 14 at 5:04 PM
	Teva Pharma Spiked To Perrigo's Detriment On Asthma Inhaler Delay finance.yahoo.com - May 14 at 5:04 PM
	Perrigo (PRGO) Rating Reiterated by Wells Fargo www.americanbankingnews.com - May 14 at 12:42 PM
	Perrigo Delay A Positive For Teva Pharma (TEVA) - Citi www.streetinsider.com - May 14 at 9:04 AM
	Perrigo (PRGO) Receives Consensus Recommendation of "Hold" from Analysts www.americanbankingnews.com - May 13 at 11:18 AM
	Brokerages Expect Perrigo (PRGO) Will Post Earnings of $1.25 Per Share www.americanbankingnews.com - May 13 at 3:12 AM
	Teva Pharma (TEVA) on Watch After Perrigo (PRGO) Says it Does Not Expect to Meet Goal of Launching Generic ... www.streetinsider.com - May 12 at 9:03 AM
	Perrigo (PRGO) Given a $98.00 Price Target by Oppenheimer Analysts www.americanbankingnews.com - May 11 at 6:13 PM
	Perrigo (PRGO) Says it Expects CRL on Generic Version Of ProAir www.streetinsider.com - May 11 at 5:25 PM
	Perrigo Drops After Saying FDA to Reject Inhaler, Delaying Start www.bloomberg.com - May 11 at 5:25 PM
	Perrigo no longer expects to get approval for generic ProAir this year www.cnbc.com - May 11 at 5:25 PM
	BRIEF-Perrigo Expects Complete Response Letter On Generic Version Of Proair www.reuters.com - May 11 at 5:25 PM
	Perrigo Expects Complete Response Letter On Generic Version Of ProAir® finance.yahoo.com - May 11 at 5:25 PM
	Perrigo no longer expects to get approval for generic Pro... finance.yahoo.com - May 11 at 5:25 PM
	Perrigo shares falls after company trims 2018 outlook finance.yahoo.com - May 11 at 5:25 PM
	[$$] FDA Rejects Perrigo's ProAir Generic, Drug Maker Says finance.yahoo.com - May 11 at 5:25 PM
	Leerink Swann Weighs in on Perrigo's Q2 2018 Earnings (PRGO) www.americanbankingnews.com - May 11 at 9:35 AM
	June 29th Options Now Available For Perrigo Company (PRGO) www.nasdaq.com - May 10 at 5:27 PM
	Perrigo (PRGO) Downgraded by ValuEngine to Sell www.americanbankingnews.com - May 10 at 1:28 PM
	Leerink Swann Analysts Boost Earnings Estimates for Perrigo (PRGO) www.americanbankingnews.com - May 10 at 7:38 AM
	Edited Transcript of PRGO earnings conference call or presentation 8-May-18 12:30pm GMT finance.yahoo.com - May 9 at 8:47 AM
	See what the IHS Markit Score report has to say about Perrigo Company PLC. finance.yahoo.com - May 9 at 8:47 AM
	Form 10-Q PERRIGO Co plc For: Mar 31 www.streetinsider.com - May 8 at 5:12 PM
	Perrigo Plc (PRGO) Q1 2018 Results - Earnings Call Transcript seekingalpha.com - May 8 at 5:12 PM
	Valeant Upside, Shire Buyout Don't Rally Pharma Stocks finance.yahoo.com - May 8 at 5:12 PM
	Perrigo (PRGO) Misses on Earnings in Q1, Reiterates View finance.yahoo.com - May 8 at 5:12 PM
	Perrigo (PRGO) Posts Earnings Results, Beats Expectations By $0.12 EPS www.americanbankingnews.com - May 8 at 12:30 PM
	Perrigo (PRGO) Issues FY18 Earnings Guidance www.americanbankingnews.com - May 8 at 10:10 AM
	Perrigo Q1 18 Earnings Conference Call At 8:30 AM ET www.nasdaq.com - May 8 at 8:40 AM
	Earnings Reaction History: Perrigo Company, 55.6% Follow-Through Indicator, 7.6% Sensitive www.nasdaq.com - May 8 at 8:40 AM
	Perrigo Co. Q1 Results Climb, Top Estimates; Backs FY18 Outlook - Quick Facts www.nasdaq.com - May 8 at 8:40 AM
	Perrigo Co. Q1 adjusted earnings of $1.26 per share www.nasdaq.com - May 8 at 8:40 AM
	Perrigo beats by $0.12, beats on revenue seekingalpha.com - May 8 at 2:39 AM
	Perrigo Company plc Reports First Quarter 2018 Financial Results www.prnewswire.com - May 8 at 1:43 AM
	Perrigo (PRGO) Announces Quarterly Dividend of $0.19 www.americanbankingnews.com - May 3 at 1:36 PM

Perrigo (NYSE:PRGO) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Perrigo (NYSE:PRGO) Income Statement, Balance Sheet and Cash Flow Statement

Perrigo (NYSE PRGO) Stock Chart for Wednesday, May, 23, 2018

Loading chart…

This page was last updated on 5/23/2018 by MarketBeat.com Staff